<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:media="http://search.yahoo.com/mrss/" >

<channel>
	<title>ISRG &#8211; Stock Earnings</title>
	<atom:link href="https://cms.stocksearning.com/tag/isrg/feed/" rel="self" type="application/rss+xml" />
	<link>https://cms.stocksearning.com</link>
	<description>Empowering Investors and Traders</description>
	<lastBuildDate>Wed, 21 Oct 2026 17:17:19 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://cms.stocksearning.com/wp-content/uploads/2025/10/cropped-cropped-SE_lovo_bimi-32x32.jpg</url>
	<title>ISRG &#8211; Stock Earnings</title>
	<link>https://cms.stocksearning.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Intuitive Surgical Beats Earnings, but 3 Risks Hit ISRG Stock</title>
		<link>https://cms.stocksearning.com/2026/10/intuitive-surgical-3-risks-to-watch/</link>
					<comments>https://cms.stocksearning.com/2026/10/intuitive-surgical-3-risks-to-watch/#respond</comments>
		
		<dc:creator><![CDATA[Ian Cooper]]></dc:creator>
		<pubDate>Wed, 21 Oct 2026 17:15:00 +0000</pubDate>
				<category><![CDATA[Post-Earnings]]></category>
		<category><![CDATA[ISRG]]></category>
		<guid isPermaLink="false">https://cms.stocksearning.com/?p=9443</guid>

					<description><![CDATA[Intuitive Surgical is growing, but shareholders are looking for a clearer reason to expect more.]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph"><strong><a href="https://stocksearning.com/stocks/ISRG/earnings-date">Intuitive Surgical (NASDAQ: ISRG)</a></strong> delivered strong third-quarter earnings, growing revenue and rising demand for its robotic surgery systems. But investors still sent the stock sharply lower. Unfortunately, a $450 million antitrust settlement and a procedure-growth forecast that offered little upside appeared to overshadow the company’s better-than-expected results.</p>



<div class="wp-block-rank-math-toc-block" id="rank-math-toc"><h2>Table of Contents</h2><nav><ul><li><a href="#intuitive-surgicals-450-million-settlement-weighs-on-earnings">Intuitive Surgical’s $450 Million Settlement Weighs on Earnings</a></li><li><a href="#da-vinci-and-ion-systems-drive-strong-procedure-and-placement-growth">Da Vinci and Ion Systems Drive Strong Procedure and Placement Growth</a></li><li><a href="#intuitive-surgicals-2026-growth-forecast-offers-little-upside">Intuitive Surgical’s 2026 Growth Forecast Offers Little Upside</a></li><li><a href="#isrg-stock-reclaims-its-50-day-moving-average">ISRG Stock Reclaims Its 50-Day Moving Average</a><ul><li><a href="#key-isrg-stock-levels-to-watch">Key ISRG Stock Levels to Watch</a></li></ul></li><li><a href="#what-intuitive-surgical-investors-should-watch-next">What Intuitive Surgical Investors Should Watch Next</a></li></ul></nav></div>



<p class="wp-block-paragraph">The medical device company reported adjusted earnings of $3 per share on revenue of $3.05 billion. Earnings beat expectations by 36 cents, while revenue topped forecasts by approximately $140 million.&nbsp;</p>



<p class="wp-block-paragraph">Revenue increased roughly 22% from a year earlier. <a href="https://stocksearning.com/stocks/ISRG/eps-chart">Adjusted earnings also improved from $2.40 per share</a>, representing growth of 25%.</p>



<p class="wp-block-paragraph">However, adjusted earnings exclude certain expenses. Investors also need to understand what happened to profits under standard accounting rules, particularly when a large legal charge creates a meaningful difference between the two measures. In this case, that difference was significant.</p>



<h2 id="intuitive-surgicals-450-million-settlement-weighs-on-earnings" class="wp-block-heading">Intuitive Surgical’s $450 Million Settlement Weighs on Earnings</h2>



<p class="wp-block-paragraph">Intuitive Surgical recorded a <a href="https://files.quartr.com/reports/03114fa21367c0d51231e228be47771f-2026-10-20-20-06-22.pdf?ref=TWFya2V0QmVhdCBNZWRpYSBMTEM=" target="_blank" rel="noopener">$450 million pretax charge</a> tied to the settlement of previously disclosed antitrust class-action litigation. After taxes, the settlement charge reduced earnings by 99 cents per diluted share. Reported earnings came in at $1.49 per share, compared with $1.95 a year earlier. </p>



<p class="wp-block-paragraph">The agreement remains subject to court approval, and Intuitive reached it without admitting liability or wrongdoing. That, unfortunately, overshadowed some of its better numbers.</p>



<h2 id="da-vinci-and-ion-systems-drive-strong-procedure-and-placement-growth" class="wp-block-heading">Da Vinci and Ion Systems Drive Strong Procedure and Placement Growth</h2>



<p class="wp-block-paragraph">Beyond the settlement, Intuitive Surgical’s operating results offered several encouraging signs. Worldwide procedures using its da Vinci and Ion systems increased approximately 15%. Da Vinci procedures rose about 14%, while Ion procedures grew about 31%.</p>



<p class="wp-block-paragraph">System placements also remained strong. Intuitive placed 546 da Vinci systems during the quarter, compared with 427 a year earlier. That represents an increase of approximately 28%. The total included 315 da Vinci 5 systems, up from 240. Its installed da Vinci base reached 12,094 systems, an increase of 12%. Ion also expanded. The company placed 56 systems, compared with 50 a year earlier, bringing its installed base to 1,152 systems, up 21%.</p>



<p class="wp-block-paragraph">Together, these figures show that customers continued adding equipment and using Intuitive’s technology more frequently. Both trends matter for future growth.</p>



<h2 id="intuitive-surgicals-2026-growth-forecast-offers-little-upside" class="wp-block-heading">Intuitive Surgical’s 2026 Growth Forecast Offers Little Upside</h2>



<p class="wp-block-paragraph">Intuitive Surgical’s updated procedure forecast helps explain why the positive operating numbers failed to lift the stock. Intuitive now expects worldwide da Vinci procedure growth of 14% to 15% for 2026, with results closer to the midpoint. Previously, management expected growth of 13.5% to 15.5%, also near the midpoint. Both ranges have the same midpoint of 14.5%.</p>



<p class="wp-block-paragraph">In other words, management narrowed the range without raising its central expectation. Against the supplied Wall Street forecast of 14.6%, the update offered little reason to increase growth assumptions. There was better news on profitability. Intuitive raised its adjusted gross-margin outlook to 68.7% to 69.3%, from 68% to 69%. Its forecast for adjusted operating-expense growth remained unchanged at 11% to 13%.</p>



<p class="wp-block-paragraph">That combination provides some encouragement: management sees a better gross-profit outlook while maintaining its spending-growth expectations.&nbsp;</p>



<p class="wp-block-paragraph">For shareholders, the next step is watching whether stronger system placements translate into sustained procedure growth and improving profits.</p>



<h2 id="isrg-stock-reclaims-its-50-day-moving-average" class="wp-block-heading">ISRG Stock Reclaims Its 50-Day Moving Average</h2>



<p class="wp-block-paragraph"><a href="https://stocksearning.com/stocks/ISRG/stock-chart">Intuitive Surgical&#8217;s chart</a> shows a notable recovery after a prolonged decline from its late-2025 and early-2026 highs. ISRG recently rallied from its September low near $350 to $431.94, despite falling 1.38% in the latest session.</p>



<p class="wp-block-paragraph">Shares are now trading above their 50-day simple moving average of $394.26, a bullish development that suggests the stock&#8217;s near-term trend has improved. The moving average is also beginning to turn higher, potentially providing support if the recovery continues.</p>



<p class="wp-block-paragraph">Momentum indicators reinforce the improving picture. The MACD line stands at 11.77, above its signal line at 10.68, while the positive histogram reading of 1.09 indicates bullish momentum remains in place. However, the stock is approaching potential resistance in the $440–$450 area, where traders may look for evidence of a sustained breakout.</p>



<h3 id="key-isrg-stock-levels-to-watch" class="wp-block-heading">Key ISRG Stock Levels to Watch</h3>



<ul class="wp-block-list">
<li>Resistance: $440–$450. A sustained move above this zone could strengthen the recovery.</li>



<li>Near-term support: Around $400–$410, an area to monitor if shares pull back.</li>



<li>Moving-average support: Approximately $394, where the 50-day moving average currently sits.</li>
</ul>



<p class="wp-block-paragraph">The technical setup is improving, but a single session&#8217;s decline does not establish a reversal. Holding above the moving average and breaking through resistance would provide stronger confirmation that the recovery has room to continue.</p>



<figure class="wp-block-image size-large"><img fetchpriority="high" decoding="async" width="600" height="315" data-source="article-image" src="https://cms.stocksearning.com/wp-content/uploads/2026/10/ISRG_2026-10-21_12-21-59-600x315.png" alt="intuitive surgical - StockEarnings" class="wp-image-9466" srcset="https://cms.stocksearning.com/wp-content/uploads/2026/10/ISRG_2026-10-21_12-21-59-600x315.png 600w, https://cms.stocksearning.com/wp-content/uploads/2026/10/ISRG_2026-10-21_12-21-59-300x158.png 300w, https://cms.stocksearning.com/wp-content/uploads/2026/10/ISRG_2026-10-21_12-21-59-768x403.png 768w, https://cms.stocksearning.com/wp-content/uploads/2026/10/ISRG_2026-10-21_12-21-59.png 1438w" sizes="(max-width: 600px) 100vw, 600px" /></figure>



<h2 id="what-intuitive-surgical-investors-should-watch-next" class="wp-block-heading">What Intuitive Surgical Investors Should Watch Next</h2>



<p class="wp-block-paragraph"><a href="https://stocksearning.com/stocks/ISRG">Intuitive Surgical </a>still has plenty working in its favor. Hospitals are adding systems, procedure volumes are growing, and the company raised its gross-margin outlook. Those are encouraging signs, even if the settlement and growth forecast left investors disappointed.</p>



<p class="wp-block-paragraph">The challenge now is turning that progress into stronger expectations for the quarters ahead. Investors will want to see continued demand, healthy profits, and evidence that newly installed systems are getting more use. This quarter shows why a beat alone may not lift a stock. Intuitive Surgical is growing, but shareholders are looking for a clearer reason to expect more.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://cms.stocksearning.com/2026/10/intuitive-surgical-3-risks-to-watch/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>How to Safely Invest in the Future of AI With ETFs</title>
		<link>https://cms.stocksearning.com/2026/05/invest-in-the-future-of-ai-with-etfs/</link>
					<comments>https://cms.stocksearning.com/2026/05/invest-in-the-future-of-ai-with-etfs/#respond</comments>
		
		<dc:creator><![CDATA[Ian Cooper]]></dc:creator>
		<pubDate>Fri, 22 May 2026 20:00:00 +0000</pubDate>
				<category><![CDATA[Evergreen]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[AIQ]]></category>
		<category><![CDATA[AMD]]></category>
		<category><![CDATA[AVGO]]></category>
		<category><![CDATA[BOTZ]]></category>
		<category><![CDATA[DT]]></category>
		<category><![CDATA[ISRG]]></category>
		<category><![CDATA[KYCCF]]></category>
		<category><![CDATA[META]]></category>
		<category><![CDATA[msft]]></category>
		<category><![CDATA[NFLX]]></category>
		<category><![CDATA[NVDA]]></category>
		<category><![CDATA[ORCL]]></category>
		<category><![CDATA[PLTR]]></category>
		<category><![CDATA[SMCAY]]></category>
		<category><![CDATA[UPST]]></category>
		<guid isPermaLink="false">https://cms.stocksearning.com/?p=2128</guid>

					<description><![CDATA[As AI technology transforms many industries investors are searching for ways to invest in the future of AI without assuming single stock risk.]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">Artificial intelligence is quickly becoming one of the biggest investment opportunities of the decade. As AI technology transforms industries like healthcare, finance, robotics, cybersecurity, and cloud computing, investors are searching for ways to invest in the future of AI without assuming single stock risk.</p>



<div class="wp-block-rank-math-toc-block" id="rank-math-toc"><h2>Table of Contents</h2><nav><ul><li><a href="#why-investors-are-looking-beyond-individual-ai-stocks">Why Investors Are Looking Beyond Individual AI Stocks</a><ul><li><a href="#global-x-artificial-intelligence-technology-etf">Global X Artificial Intelligence &amp; Technology ETF</a></li><li><a href="#global-x-robotics-and-artificial-intelligence-etf">Global X Robotics and Artificial Intelligence ETF </a></li></ul></li><li><a href="#et-fs-can-help-you-capture-the-future-of-ai">ETFs Can Help You Capture the Future of AI</a></li></ul></nav></div>



<p class="wp-block-paragraph">From machine learning and automation to generative AI tools and advanced semiconductors, the artificial intelligence market is expected to expand rapidly over the next several years, creating major opportunities for both companies and investors.</p>



<p class="wp-block-paragraph">According to <em>Grand View Research</em>, the global AI market could expand from about <a href="https://www.grandviewresearch.com/industry-analysis/artificial-intelligence-ai-market" target="_blank" rel="noopener">$137 billion in 2022 to more than $1.8 trillion by 2030</a>. Other studies suggest AI may add trillions of dollars to the global economy over the next decade as companies use it to improve productivity, lower costs, and increase profits.</p>



<p class="wp-block-paragraph">Because of this massive potential, many investors want exposure to AI-related stocks. Investors are increasingly viewing artificial intelligence as a long-term megatrend similar to the early growth of the internet or cloud computing. That excitement has helped fuel significant gains in many AI stocks, but it has also increased volatility as valuations rise and competition intensifies across the sector. For newer investors, especially, finding a balanced way to participate in the future of AI without taking excessive risk has become an important part of building a long-term portfolio.</p>



<p class="wp-block-paragraph">Companies like <a href="https://stocksearning.com/stocks/NVDA/earnings-date"><strong>NVIDIA (NASDAQ: NVDA)</strong> </a>and <strong><a href="https://stocksearning.com/stocks/AMD/earnings-date">Advanced Micro Devices (NASDAQ: AMD)</a></strong> have become popular choices because they help power AI systems through advanced computer chips and data center technology. However, choosing the right AI stocks can be difficult. The industry changes quickly, competition is intense, and even promising companies can experience large swings in price.</p>



<p class="wp-block-paragraph">For investors who want a simpler and potentially safer way to invest in the future of AI, exchange-traded funds (ETFs) can be a smart option. AI ETFs allow investors to own a collection of companies connected to artificial intelligence instead of relying on a single stock. This diversification can reduce risk while still providing exposure to the fast-growing AI market.</p>



<h2 class="wp-block-heading" id="why-investors-are-looking-beyond-individual-ai-stocks">Why Investors Are Looking Beyond Individual AI Stocks</h2>



<h3 class="wp-block-heading" id="global-x-artificial-intelligence-technology-etf">Global X Artificial Intelligence &amp; Technology ETF </h3>



<p class="wp-block-paragraph">One ETF many investors consider is the AIQ, also known as the <strong>Global X Artificial Intelligence &amp; Technology ETF (NASDAQ: AIQ)</strong>. This fund focuses on companies that could benefit from the development and use of AI technologies across different industries. The ETF has an expense ratio of 0.68%, making it a relatively affordable way to gain broad exposure to the AI sector.</p>



<p class="wp-block-paragraph">The fund includes major technology companies and AI leaders such as <strong>Palantir Technologies (NASDAQ: PLTR)</strong>, <strong>Oracle (NYSE: ORCL</strong>), <strong>Broadcom (NASDAQ: AVGO)</strong>, <strong>Netflix (NASDAQ: NFLX)</strong>, <strong>Microsoft (NASDAQ: MSFT)</strong>, and <strong>Meta Platforms (NASDAQ: META)</strong>. By investing in multiple companies, the ETF spreads risk across different parts of the AI industry, including cloud computing, software, semiconductors, and digital platforms.</p>



<figure class="wp-block-image size-large"><img decoding="async" width="600" height="312" data-source="article-image" src="https://cms.stocksearning.com/wp-content/uploads/2026/05/AIQ_2026-05-22_15-29-23-600x312.png" alt="the future of ai - StockEarnings" class="wp-image-2135" srcset="https://cms.stocksearning.com/wp-content/uploads/2026/05/AIQ_2026-05-22_15-29-23-600x312.png 600w, https://cms.stocksearning.com/wp-content/uploads/2026/05/AIQ_2026-05-22_15-29-23-300x156.png 300w, https://cms.stocksearning.com/wp-content/uploads/2026/05/AIQ_2026-05-22_15-29-23-768x400.png 768w, https://cms.stocksearning.com/wp-content/uploads/2026/05/AIQ_2026-05-22_15-29-23.png 1160w" sizes="(max-width: 600px) 100vw, 600px" /></figure>



<h3 class="wp-block-heading" id="global-x-robotics-and-artificial-intelligence-etf">Global X Robotics and Artificial Intelligence ETF&nbsp;</h3>



<p class="wp-block-paragraph">Another one of the top AI ETFs to consider for the future of AI is the <strong>Global X Robotics and Artificial Intelligence ETF (NASDAQ: BOTZ)</strong>. With an expense ratio of 0.68%, the ETF invests in companies that should benefit from the increased adoption of robotics and AI. Some of its 49 holdings include <strong>NVIDIA (NASDAQ: NVDA)</strong>, <strong>Keyence (OTCMKTS: KYCCF)</strong>, <strong>DynaTrace (NYSE: DT)</strong>, <strong>SMC Corp. (OTCMKTS: SMCAY)</strong>, <strong>Intuitive Surgical (NASDAQ: ISRG)</strong>, <strong>Upstart Holdings (NASDAQ: UPST)</strong>, and <strong>C3.ai (NYSE: AI)</strong>. </p>



<figure class="wp-block-image size-large"><img decoding="async" width="600" height="312" data-source="article-image" src="https://cms.stocksearning.com/wp-content/uploads/2026/05/BOTZ_2026-05-22_15-29-44-600x312.png" alt="the future of ai - StockEarnings" class="wp-image-2136" srcset="https://cms.stocksearning.com/wp-content/uploads/2026/05/BOTZ_2026-05-22_15-29-44-600x312.png 600w, https://cms.stocksearning.com/wp-content/uploads/2026/05/BOTZ_2026-05-22_15-29-44-300x156.png 300w, https://cms.stocksearning.com/wp-content/uploads/2026/05/BOTZ_2026-05-22_15-29-44-768x400.png 768w, https://cms.stocksearning.com/wp-content/uploads/2026/05/BOTZ_2026-05-22_15-29-44.png 1160w" sizes="(max-width: 600px) 100vw, 600px" /></figure>



<h2 class="wp-block-heading" id="et-fs-can-help-you-capture-the-future-of-ai">ETFs Can Help You Capture the Future of AI </h2>



<p class="wp-block-paragraph">Artificial intelligence is expected to remain one of the fastest-growing sectors in the global economy for years to come. As companies continue investing in machine learning, automation, robotics, and AI-powered software, investors have an opportunity to benefit from the industry’s long-term expansion. While individual AI stocks like NVIDIA and Advanced Micro Devices may continue to attract attention, AI-focused ETFs can provide a diversified approach to investing in this rapidly exploding market.</p>



<p class="wp-block-paragraph">For long-term investors, AI ETFs may represent one of the most practical ways to participate in the future of AI while managing risk. Instead of depending on a single company to dominate the industry, ETFs allow investors to benefit from broader trends across semiconductors, cloud infrastructure, software, robotics, and automation. As artificial intelligence adoption expands throughout the global economy, diversified AI ETFs could continue to attract investors seeking both growth potential and a more balanced approach to one of the market’s most transformative technologies.</p>



<p class="wp-block-paragraph"></p>
]]></content:encoded>
					
					<wfw:commentRss>https://cms.stocksearning.com/2026/05/invest-in-the-future-of-ai-with-etfs/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Best AI ETFs: 2 Smart Ways to Invest in Artificial Intelligence</title>
		<link>https://cms.stocksearning.com/2026/05/best-ai-etfs-to-invest-in-ai-growth/</link>
					<comments>https://cms.stocksearning.com/2026/05/best-ai-etfs-to-invest-in-ai-growth/#respond</comments>
		
		<dc:creator><![CDATA[Ian Cooper]]></dc:creator>
		<pubDate>Fri, 01 May 2026 20:00:00 +0000</pubDate>
				<category><![CDATA[Evergreen]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[AIQ]]></category>
		<category><![CDATA[AVGO]]></category>
		<category><![CDATA[BOTZ]]></category>
		<category><![CDATA[DT]]></category>
		<category><![CDATA[ISRG]]></category>
		<category><![CDATA[KYCCF]]></category>
		<category><![CDATA[META]]></category>
		<category><![CDATA[msft]]></category>
		<category><![CDATA[NFLX]]></category>
		<category><![CDATA[NVDA]]></category>
		<category><![CDATA[ORCL]]></category>
		<category><![CDATA[PLTR]]></category>
		<category><![CDATA[UPST]]></category>
		<guid isPermaLink="false">https://cms.stocksearning.com/?p=1874</guid>

					<description><![CDATA[For most investors, AI ETFs offer a stable and diversified path to participate in the sector’s growth without constantly monitor individual companies.]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">AI ETFs are quickly becoming one of the simplest ways to invest in artificial intelligence, especially as the sector’s long-term growth outlook continues to strengthen. It’s very clear that artificial intelligence is here to stay.</p>



<div class="wp-block-rank-math-toc-block" id="rank-math-toc"><h2>Table of Contents</h2><nav><ul><li><a href="#why-ai-et-fs-are-a-smart-way-to-invest-in-artificial-intelligence">Why AI ETFs Are a Smart Way to Invest in Artificial Intelligence</a></li><li><a href="#aiq-etf-broad-exposure-to-artificial-intelligence-leaders">AIQ ETF: Broad Exposure to Artificial Intelligence Leaders</a></li><li><a href="#botz-etf-targeted-exposure-to-robotics-and-ai-innovation">BOTZ ETF: Targeted Exposure to Robotics and AI Innovation</a></li><li><a href="#the-case-for-ai-et-fs-as-a-long-term-investment-strategy">The Case for AI ETFs as a Long-Term Investment Strategy</a></li></ul></nav></div>



<p class="wp-block-paragraph">According to <em>Grand View Research</em>, the global AI boom could grow from about $137 billion in 2022 to more than <a href="https://www.grandviewresearch.com/industry-analysis/artificial-intelligence-ai-market" target="_blank" rel="noopener">$1.81 trillion by 2030</a>. Meanwhile, the Marketing AI Institute notes that artificial intelligence could boost profitability by 38% on average and contribute up to $14 trillion in additional global economic value by 2035, based on Accenture research.</p>



<p class="wp-block-paragraph">MIT Technology Review has also highlighted the rapid pace of change, noting that AI could rival or surpass human capabilities across many domains within decades. For investors, that kind of growth trajectory signals a major long-term opportunity</p>



<p class="wp-block-paragraph">However, that opportunity also raises a key question: what’s the smartest way to gain exposure? For those hesitant to pick individual winners beyond names like NVDA or AMD, AI ETFs offer a more balanced and accessible approach.</p>



<h2 class="wp-block-heading" id="why-ai-et-fs-are-a-smart-way-to-invest-in-artificial-intelligence">Why AI ETFs Are a Smart Way to Invest in Artificial Intelligence</h2>



<p class="wp-block-paragraph">AI ETFs allow you to invest in a diversified basket of companies involved in artificial intelligence, automation, and related technologies. Instead of betting on a single stock, you gain exposure to an entire ecosystem—from chipmakers and cloud providers to software developers and robotics firms.</p>



<p class="wp-block-paragraph">This diversification helps reduce risk while still allowing you to benefit from the overall growth of the AI industry. It also saves time and effort, since professional fund managers handle the selection and rebalancing of holdings.</p>



<h2 class="wp-block-heading" id="aiq-etf-broad-exposure-to-artificial-intelligence-leaders">AIQ ETF: Broad Exposure to Artificial Intelligence Leaders</h2>



<p class="wp-block-paragraph">If you want diversified AI exposure at a reasonable cost, the <strong>Global X Artificial Intelligence &amp; Technology ETF (NASDAQ: AIQ)</strong> is a strong option.</p>



<p class="wp-block-paragraph">With an expense ratio of 0.68%, the ETF invests in companies that potentially stand to benefit from the further development and utilization of artificial intelligence (AI) technology.</p>



<p class="wp-block-paragraph">Some of its top holdings include <strong><a href="https://stocksearning.com/stocks/PLTR/earnings-date">Palantir Technologies (NASDAQ: PLTR)</a></strong>, <strong><a href="https://stocksearning.com/stocks/ORCL/earnings-date">Oracle (NYSE: ORCL)</a></strong>, <strong><a href="https://stocksearning.com/stocks/AVGO/earnings-date">Broadcom (NASDAQ: AVGO)</a></strong>, <strong><a href="https://stocksearning.com/stocks/NFLX/earnings-date">Netflix (NASDAQ: NFLX)</a></strong>, <strong><a href="https://stocksearning.com/stocks/NVDA/earnings-date">NVIDIA (NASDAQ: NVDA)</a></strong>, <strong><a href="https://stocksearning.com/stocks/MSFT/earnings-date">Microsoft (NASDAQ: MSFT)</a></strong>, and <strong>Meta Platforms (NASDAQ: META)</strong>.</p>



<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="600" height="312" data-source="article-image" src="https://cms.stocksearning.com/wp-content/uploads/2026/05/AIQ_2026-05-01_14-28-20-600x312.png" alt="AI ETFs - StockEarnings" class="wp-image-1884" srcset="https://cms.stocksearning.com/wp-content/uploads/2026/05/AIQ_2026-05-01_14-28-20-600x312.png 600w, https://cms.stocksearning.com/wp-content/uploads/2026/05/AIQ_2026-05-01_14-28-20-300x156.png 300w, https://cms.stocksearning.com/wp-content/uploads/2026/05/AIQ_2026-05-01_14-28-20-768x400.png 768w, https://cms.stocksearning.com/wp-content/uploads/2026/05/AIQ_2026-05-01_14-28-20.png 1160w" sizes="auto, (max-width: 600px) 100vw, 600px" /></figure>



<h2 class="wp-block-heading" id="botz-etf-targeted-exposure-to-robotics-and-ai-innovation">BOTZ ETF: Targeted Exposure to Robotics and AI Innovation</h2>



<p class="wp-block-paragraph">Another top option is the <strong><strong>Global X Robotics and Artificial Intelligence ETF (NASDAQ: BOTZ)</strong></strong>, which focuses more specifically on robotics and automation.</p>



<p class="wp-block-paragraph">Also carrying an expense ratio of 0.68%, BOTZ includes around 40–50 holdings such as <strong>N</strong>VIDIA, <strong>Keyence (OTCMKTS: KYCCF)</strong>, <strong><a href="https://stocksearning.com/stocks/DT/earnings-date">DynaTrace (NYSE: DT)</a></strong>, <strong><a href="https://stocksearning.com/stocks/ISRG/earnings-date">Intuitive Surgical (NASDAQ: ISRG)</a></strong>, <strong><a href="https://stocksearning.com/stocks/UPST/earnings-date">Upstart Holdings (NASDAQ: UPST)</a></strong>, and <strong>C3.ai (NYSE: AI)</strong>. This ETF leans more heavily into industrial automation and robotics, offering a slightly more concentrated bet on how AI is transforming physical industries.</p>



<p class="wp-block-paragraph">For investors who want targeted exposure to robotics alongside AI, BOTZ provides a compelling complement to broader AI ETFs.</p>



<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="600" height="312" data-source="article-image" src="https://cms.stocksearning.com/wp-content/uploads/2026/05/BOTZ_2026-05-01_14-29-00-600x312.png" alt="ai ETFs - StockEarnings" class="wp-image-1883" srcset="https://cms.stocksearning.com/wp-content/uploads/2026/05/BOTZ_2026-05-01_14-29-00-600x312.png 600w, https://cms.stocksearning.com/wp-content/uploads/2026/05/BOTZ_2026-05-01_14-29-00-300x156.png 300w, https://cms.stocksearning.com/wp-content/uploads/2026/05/BOTZ_2026-05-01_14-29-00-768x400.png 768w, https://cms.stocksearning.com/wp-content/uploads/2026/05/BOTZ_2026-05-01_14-29-00.png 1160w" sizes="auto, (max-width: 600px) 100vw, 600px" /></figure>



<h2 class="wp-block-heading" id="the-case-for-ai-et-fs-as-a-long-term-investment-strategy">The Case for AI ETFs as a Long-Term Investment Strategy</h2>



<p class="wp-block-paragraph">Artificial intelligence is shaping up to be one of the most important investment themes of the next decade, and AI ETFs provide a practical way to gain exposure without taking on unnecessary risk. Instead of trying to predict which single company will dominate, funds like AIQ and BOTZ allow investors to participate in the broader ecosystem and drive innovation.</p>



<p class="wp-block-paragraph">This approach is particularly valuable in a fast-evolving sector like AI, where leadership can shift quickly, and new technologies can disrupt incumbents. By investing in AI ETFs, you’re effectively positioning your portfolio to benefit from multiple growth drivers, including semiconductors, cloud computing, enterprise software, and robotics.</p>



<p class="wp-block-paragraph">Over time, that diversification can help smooth returns while still capturing meaningful upside. For investors looking to balance growth potential with risk management, AI ETFs stand out as one of the most efficient ways to invest in artificial intelligence today.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://cms.stocksearning.com/2026/05/best-ai-etfs-to-invest-in-ai-growth/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Medtronic: Earnings Show Strong Growth, But Is Upside Limited?</title>
		<link>https://cms.stocksearning.com/2026/02/medtronic-strong-growth-small-upside/</link>
					<comments>https://cms.stocksearning.com/2026/02/medtronic-strong-growth-small-upside/#respond</comments>
		
		<dc:creator><![CDATA[Chris Markoch]]></dc:creator>
		<pubDate>Wed, 18 Feb 2026 12:00:00 +0000</pubDate>
				<category><![CDATA[Post-Earnings]]></category>
		<category><![CDATA[IHI]]></category>
		<category><![CDATA[ISRG]]></category>
		<category><![CDATA[MDT]]></category>
		<guid isPermaLink="false">https://cms.stocksearning.com/?p=1174</guid>

					<description><![CDATA[Medtronic delivered a strong report, but full-year guidance was only in line with its prior forecast, reflecting the continued impact of tariffs. ]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph"><a href="https://stocksearning.com/stocks/MDT/earnings-date" target="_blank" rel="noreferrer noopener"><strong>Medtronic (NYSE: MDT)</strong></a>&nbsp;stock&nbsp;fell almost 3% on a day when it reported solid earnings, including 8.7% enterprise revenue growth in Q3 fiscal 2026. One of the key takeaways from that growth number was that 6% of the growth was organic. That was a theme that investors heard throughout the company’s presentation.&nbsp;&nbsp;</p>



<div class="wp-block-rank-math-toc-block" id="rank-math-toc"><h2>Table of Contents</h2><nav><ul><li><a href="#organic-growth-is-the-key">Organic Growth is the Key </a></li><li><a href="#growth-in-this-sector-seems-inevitable">Growth In This Sector Seems Inevitable </a></li><li><a href="#two-ideas-for-mdt-stock">Two Ideas for MDT Stock </a></li><li><a href="#medtronic-the-investment-verdict">Medtronic: The Investment Verdict </a></li></ul></nav></div>



<p class="wp-block-paragraph">By almost any&nbsp;metric,&nbsp;this was a strong report and one that investors have&nbsp;been&nbsp;waiting&nbsp;on&nbsp;for some time. But the company offered full-year guidance that was only in line with its prior forecast, which was due to the continued impact of tariffs.&nbsp;</p>



<p class="wp-block-paragraph">That had analysts questioning how much growth was left in a stock that hit a 52-week high in December 2025.&nbsp;Analysts were bullish on MDT stock prior to the earnings report, so&nbsp;it’s&nbsp;a good idea&nbsp;to dive into the report to see if Medtronic belongs in your portfolio or on a watchlist.&nbsp;&nbsp;</p>



<h2 class="wp-block-heading" id="organic-growth-is-the-key">Organic Growth is the Key&nbsp;</h2>



<p class="wp-block-paragraph">The core of&nbsp;Medtronic’s growth story&nbsp;lies in&nbsp;its robust organic revenue expansion.&nbsp;This&nbsp;metric strips away currency fluctuations, acquisitions, and divestitures to reveal the underlying health of&nbsp;a company’s&nbsp;operations. In Q3 fiscal 2026, Medtronic delivered worldwide revenue of&nbsp;$9.017 billion, reflecting 8.7% reported growth and a standout&nbsp;6% organic increase.&nbsp;That was the company’s&nbsp;strongest&nbsp;quarterly performance in a decade. This exceeded internal guidance and market expectations, driven by broad-based strength across key portfolios rather than one-off events.&nbsp;</p>



<p class="wp-block-paragraph"><a href="https://files.quartr.com/conference-calls/7c6c2-2026-02-17-11-04-50.pdf?ref=TWFya2V0QmVhdCBNZWRpYSBMTEM=" target="_blank" rel="noreferrer noopener">Digging&nbsp;deeper&nbsp;into the report</a>, we see that organic growth shone brightest in&nbsp;Medtronic’s&nbsp;Cardiovascular&nbsp;business,&nbsp;which was&nbsp;up 10.6% organically, fueled by an astonishing 80% surge in Cardiac Ablation Solutions from pulsed field ablation technology rollouts and 4 percentage points of market share gain in a&nbsp;$13 billion&nbsp;addressable market.&nbsp;&nbsp;</p>



<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="600" height="331" src="https://cms.stocksearning.com/wp-content/uploads/2026/02/MDT_1-600x331.png" alt="Medtronic - StockEarnings" class="wp-image-1177" srcset="https://cms.stocksearning.com/wp-content/uploads/2026/02/MDT_1-600x331.png 600w, https://cms.stocksearning.com/wp-content/uploads/2026/02/MDT_1-300x165.png 300w, https://cms.stocksearning.com/wp-content/uploads/2026/02/MDT_1-768x423.png 768w, https://cms.stocksearning.com/wp-content/uploads/2026/02/MDT_1-1536x847.png 1536w, https://cms.stocksearning.com/wp-content/uploads/2026/02/MDT_1.png 1538w" sizes="auto, (max-width: 600px) 100vw, 600px" /></figure>



<p class="wp-block-paragraph">Cardiac Rhythm &amp; Heart Failure posted high-teens&nbsp;organic gains, while Diabetes grew 8.3% on&nbsp;MiniMed&nbsp;pump adoption and consumables. Neuroscience and Surgical Technologies added mid-single-digit organic advances, underscoring portfolio depth. Management highlighted recurring revenue streams&nbsp;through&nbsp;remote monitoring via&nbsp;CareLink, disposables like catheters and infusion sets&nbsp;as&nbsp;being the&nbsp;key to this sustainability,&nbsp;comprising&nbsp;60-70% of the mix for annuity-like stability.&nbsp;</p>



<p class="wp-block-paragraph">For the full FY26, Medtronic reiterated&nbsp;approximately&nbsp;5.5% organic revenue growth guidance, absorbing&nbsp;a&nbsp;$185 million tariff headwind, with Q4 expected to mirror Q3&#8217;s momentum. Adjusted gross margins hit 64.9%, reflecting pricing discipline and efficiency, while R&amp;D investments rose 7% to fuel pipeline launches like the Sphere-360 catheter and Hugo robot approvals.&nbsp;&nbsp;</p>



<p class="wp-block-paragraph">The takeaway for investors is that Medtronic’s report&nbsp;wasn’t&nbsp;a one-off.&nbsp;This&nbsp;is&nbsp;execution&nbsp;on a roadmap that positions Medtronic for mid-single-digit growth amid demographic tailwinds such as aging populations and procedure volumes. Investors can trust these numbers as proof of operational leverage, not just hardware cycles, setting the stage for compounded returns.&nbsp;&nbsp;</p>



<h2 class="wp-block-heading" id="growth-in-this-sector-seems-inevitable">Growth In This Sector Seems&nbsp;Inevitable&nbsp;</h2>



<p class="wp-block-paragraph">There are many reasons why thoughtful people can debate the merits of artificial intelligence (AI). But one of the most compelling applications for AI is in the field of robotics, particularly robotic surgery. This&nbsp;isn’t&nbsp;about removing the&nbsp;expertise&nbsp;of a doctor.&nbsp;It’s&nbsp;about&nbsp;providing&nbsp;the opportunity for a less invasive approach to surgery. And the applications are expanding.&nbsp;&nbsp;</p>



<p class="wp-block-paragraph">That said, Medtronic&nbsp;doesn’t&nbsp;have a moat in this sector. Many would argue it&nbsp;isn’t&nbsp;even the sector leader with&nbsp;companies like&nbsp;<a href="https://stocksearning.com/stocks/ISRG/earnings-date" target="_blank" rel="noreferrer noopener"><strong>Intuitive Surgical (NYSE: ISRG)</strong></a><strong>&nbsp;</strong>in the picture.&nbsp;&nbsp;</p>



<p class="wp-block-paragraph">However, this is an area that is primed for significant growth. According to Towardshealthcare.com, the industry will be&nbsp;<a href="https://www.towardshealthcare.com/insights/robotic-surgery-market-sizing" target="_blank" rel="noreferrer noopener">valued at&nbsp;$16.07 billion&nbsp;in 2026</a>&nbsp;but is forecasted to grow to&nbsp;$63.73 billion&nbsp;by 2035.&nbsp;That’s&nbsp;a compound annual growth rate (CAGR) of 16.54%.&nbsp;&nbsp;</p>



<p class="wp-block-paragraph">Medtronic&nbsp;won’t&nbsp;have that growth to itself. But there’s room for more than one company, and Medtronic is well-positioned to grab significant market share.&nbsp;</p>



<h2 class="wp-block-heading" id="two-ideas-for-mdt-stock">Two Ideas for MDT Stock&nbsp;</h2>



<p class="wp-block-paragraph">If you own MDT stock, your opinion about the stock will depend on how long&nbsp;you’ve&nbsp;held it.&nbsp;If you bought the stock in the last three years, you’ve done pretty well.&nbsp;The same is&nbsp;true if&nbsp;you’ve&nbsp;owned it for more than 10 years.&nbsp;&nbsp;</p>



<p class="wp-block-paragraph">But if you bought the stock at its peak in 2026,&nbsp;it’s&nbsp;been a difficult hold. The total return for MDT stock is –5.24% over that span. That includes the company’s dividend, which has a yield of 2.95%.&nbsp;&nbsp;</p>



<p class="wp-block-paragraph">That brings us back to right now. The good news is that MDT stock appears to have&nbsp;found support at its 150-day simple moving average (SMA).&nbsp;If the stock holds above that level, it could retest its 52-week&nbsp;high&nbsp;around $106.&nbsp;However, the chart also shows a potential double-top reversal around the $95-$100 pivot with weak relative strength and expanding volume on downside candles.&nbsp;&nbsp;</p>



<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="600" height="300" src="https://cms.stocksearning.com/wp-content/uploads/2026/02/MDT_2-600x300.png" alt="Medtronic - StockEarnings" class="wp-image-1176" srcset="https://cms.stocksearning.com/wp-content/uploads/2026/02/MDT_2-600x300.png 600w, https://cms.stocksearning.com/wp-content/uploads/2026/02/MDT_2-300x150.png 300w, https://cms.stocksearning.com/wp-content/uploads/2026/02/MDT_2-768x383.png 768w, https://cms.stocksearning.com/wp-content/uploads/2026/02/MDT_2.png 1216w" sizes="auto, (max-width: 600px) 100vw, 600px" /></figure>



<p class="wp-block-paragraph">Simply put, the stock needs a catalyst to push it significantly higher. And with the company’s earnings outlook coming in line with expectations,&nbsp;upside may be limited.&nbsp;Nevertheless, Medtronic does pay&nbsp;a somewhat attractive&nbsp;dividend. The current annual payout is $2.84 per share.&nbsp;More importantly, the dividend is safe. In fact, if the company increases its dividend payout as expected, it will join&nbsp;the exclusive list of Dividend Kings.&nbsp;That means it will have increased its dividend payout for at least 50 consecutive years.&nbsp;&nbsp;</p>



<p class="wp-block-paragraph">Still, if you feel MDT stock carries too much risk on its own, you can get exposure to the stock through several exchange-traded funds (ETFs). One of those is the&nbsp;<strong>iShares U.S. Medical Devices ETF (NYSEARCA: IHI)</strong>. This is a market-cap weighted&nbsp;index,&nbsp;and 4.9% of the fund is invested in MDT stock.&nbsp;&nbsp;</p>



<p class="wp-block-paragraph">Like many stocks in the&nbsp;sector,&nbsp;the performance of the fund has been choppy in the last five years. Still, if&nbsp;you’re&nbsp;looking for exposure to the field of robotic surgery without the risk of owning any&nbsp;particular stock, the IHI fund&nbsp;is a solid choice, particularly with an expense ratio of just 0.40%.&nbsp;&nbsp;</p>



<h2 class="wp-block-heading" id="medtronic-the-investment-verdict">Medtronic: The Investment Verdict&nbsp;</h2>



<p class="wp-block-paragraph">Medtronic&#8217;s Q3 organic beat and recurring revenue resilience&nbsp;affirm&nbsp;a compelling growth thesis, even if near-term tariffs cap headlines. With support at the 150-day SMA and Dividend King status looming, patient holders stand to&nbsp;benefit&nbsp;from robotic surgery tailwinds and pipeline catalysts. For conservative exposure, IHI ETF offers diversified upside at low cost—buy the dip above key supports.&nbsp;</p>



<p class="wp-block-paragraph"></p>
]]></content:encoded>
					
					<wfw:commentRss>https://cms.stocksearning.com/2026/02/medtronic-strong-growth-small-upside/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
